Please use this identifier to cite or link to this item: https://doi.org/10.1016/S1470-2045(06)70943-3
DC FieldValue
dc.titleUse of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour
dc.contributor.authorToh, Han Chong
dc.contributor.authorTeo, Marissa
dc.contributor.authorOng, K Wee Ong
dc.contributor.authorLee, Victor
dc.contributor.authorChan, Errol
dc.contributor.authorLee, Ann SG
dc.contributor.authorVathsala, Anantharaman
dc.date.accessioned2022-07-29T07:10:13Z
dc.date.available2022-07-29T07:10:13Z
dc.date.issued2006-11-01
dc.identifier.citationToh, Han Chong, Teo, Marissa, Ong, K Wee Ong, Lee, Victor, Chan, Errol, Lee, Ann SG, Vathsala, Anantharaman (2006-11-01). Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour. LANCET ONCOLOGY 7 (11) : 955-957. ScholarBank@NUS Repository. https://doi.org/10.1016/S1470-2045(06)70943-3
dc.identifier.issn1470-2045
dc.identifier.issn1474-5488
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/229452
dc.language.isoen
dc.publisherELSEVIER SCIENCE INC
dc.sourceElements
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.subjectOF-THE-LITERATURE
dc.subjectMAMMALIAN TARGET
dc.subjectRAPAMYCIN
dc.subjectTRANSPLANTATION
dc.subjectLEIOMYOSARCOMA
dc.subjectNEOPLASM
dc.typeEditorial
dc.date.updated2022-07-23T13:44:32Z
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/S1470-2045(06)70943-3
dc.description.sourcetitleLANCET ONCOLOGY
dc.description.volume7
dc.description.issue11
dc.description.page955-957
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
EBV_Smooth Muscle Tumors - Lancet Oncology.pdf170.38 kBAdobe PDF

CLOSED

Published

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.